Table 4.
Composition of SFA, MUFA, and PUFA in brain after oral administration of fish oil and krill oils
| mg/g brain | SFA | MUFA | PUFA | |
|---|---|---|---|---|
| 0 | 134.23 ± 6.17 | 62.49 ± 3.46 | 92.95 ± 5.10 | |
| 2 | FO | 157.08 ± 30.48 | 79.37 ± 10.49 | 145.54 ± 20.01 |
| KO | 137.95 ± 6.38 | 64.00 ± 3.50 | 95.25 ± 5.38 | |
| CKO | 52.42 ± 1.70 | 23.97 ± 0.57 | 35.88 ± 1.56 | |
| 4 | FO | 160.02 ± 11.26 | 69.70 ± 2.47 | 109.89 ± 7.97 |
| KO | 149.65 ± 10.97 | 71.58 ± 7.64 | 105.48 ± 7.23 | |
| CKO | 187.23 ± 9.45 | 89.63 ± 4.26 | 135.81 ± 5.74 | |
| 8 | FO | 156.47 ± 5.70 | 70.65 ± 2.13 | 120.94 ± 7.10 |
| KO | 145.98 ± 7.48 | 68.09 ± 4.72 | 107.60 ± 9.62 | |
| CKO | 174.99 ± 7.58 | 83.34 ± 3.59 | 128.49 ± 6.97 | |
| 12 | FO | 209.72 ± 6.57 | 96.30 ± 2.48 | 144.63 ± 5.07 |
| KO | 231.62 ± 6.25 | 106.51 ± 2.38 | 159.17 ± 3.91 | |
| CKO | 208.54 ± 9.68 | 98.26 ± 4.91 | 152.75 ± 10.79 | |
| 24 | FO | 201.37 ± 10.29 | 91.27 ± 4.10 | 135.75 ± 7.05 |
| KO | 233.60 ± 6.30 | 109.92 ± 3.66 | 162.32 ± 4.47 | |
| CKO | 220.05 ± 9.62 | 103.52 ± 5.41 | 158.58 ± 9.19 | |
| 48 | FO | 200.00 ± 18.25 | 86.65 ± 8.88 | 130.62 ± 13.96 |
| KO | 249.91 ± 10.49 | 114.06 ± 3.53 | 171.97 ± 6.39 | |
| CKO | 211.17 ± 8.76 | 98.65 ± 3.22 | 150.26 ± 7.70 | |
SFA: 14:0, 16:0, 18:0; MUFA: 16:1, 18:1(n-9), 18:1(n-7); PUFA: 18:2(n-6), 18:3(n-3), 18:4(n-3), 20:4(n-6), 20:5, 22:5, 22:6. Values are presented as the mean ± S.E (n = 4). One-way analysis of variance with Duncan’s multiple comparison test with mean values